PHO-COG-FALLON-ANBL00B1; Neuroblastoma Biology Studies

S
Sandeep Batra, MD

Primary Investigator

Overview

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Description

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Neuroblastoma
  • Age: - 30 Years
  • Gender: All

Inclusion Criteria
Newly diagnosed with suspected neuroblastoma, suspected ganglionneuroblastoma
Exclusion Criteria
Patients with relapsed neuroblastoma who ere not enrolled on ANBL00B1 at original diagnosis
Additional Information:
Participants will not be paid for their participation.

Updated on 02 Jan 2024. Study ID: 1011003226 (0012-27)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center